These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19135537)

  • 21. Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
    Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
    Br J Pharmacol; 2015 Sep; 172(17):4364-79. PubMed ID: 26076100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.
    Derakhchan K; Chui RW; Stevens D; Gu W; Vargas HM
    Br J Pharmacol; 2014 Jan; 171(2):509-22. PubMed ID: 24372552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
    Vormberge T; Hoffmann M; Himmel H
    J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
    Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
    Takahara A; Sugiyama A; Hashimoto K
    Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
    Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
    J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
    Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
    J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QT interval correction assessment in the anesthetized guinea pig.
    Morissette P; Regan HK; Fitzgerald K; Bernasconi S; Gerenser P; Travis J; Fanelli P; Sannajust F; Regan CP
    J Pharmacol Toxicol Methods; 2015; 75():52-61. PubMed ID: 26001325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored Consortium.
    Boulay E; Abernathy MM; Chui R; Friedrichs GS; Gendron-Parra N; Greiter-Wilke A; Guillon JM; Koerner JE; Menard A; Steidl-Nichols J; Pierson J; Pugsley MK; Rossman EI; Strauss D; Troncy E; Valentin JP; Wisialowski T; Authier S
    Int J Toxicol; 2019; 38(1):23-32. PubMed ID: 30567462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT PRODACT: sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation.
    Miyazaki H; Watanabe H; Kitayama T; Nishida M; Nishi Y; Sekiya K; Suganami H; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):523-9. PubMed ID: 16493192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
    Tattersall ML; Dymond M; Hammond T; Valentin JP
    J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
    Markert M; Shen R; Trautmann T; Guth B
    J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ECG telemetry in conscious guinea pigs.
    Ruppert S; Vormberge T; Igl BW; Hoffmann M
    J Pharmacol Toxicol Methods; 2016; 81():88-98. PubMed ID: 27118261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.
    Ando K; Hombo T; Kanno A; Ikeda H; Imaizumi M; Shimizu N; Sakamoto K; Kitani S; Yamamoto Y; Hizume S; Nakai K; Kitayama T; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):487-500. PubMed ID: 16493189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval.
    Indik JH; Pearson EC; Fried K; Woosley RL
    Heart Rhythm; 2006 Sep; 3(9):1003-7. PubMed ID: 16945790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
    Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
    J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes.
    Extramiana F; Badilini F; Sarapa N; Leenhardt A; Maison-Blanche P
    J Clin Pharmacol; 2007 Sep; 47(9):1129-37. PubMed ID: 17656619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of QT interval using a linear model in individual cynomolgus monkeys.
    Koga T; Kuwano K; Kito G; Kanefuji K
    J Pharmacol Toxicol Methods; 2007; 55(3):248-53. PubMed ID: 17141531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.